451 related articles for article (PubMed ID: 15353558)
1. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
[TBL] [Abstract][Full Text] [Related]
2. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
3. IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL.
Barata JT; Boussiotis VA; Yunes JA; Ferrando AA; Moreau LA; Veiga JP; Sallan SE; Look AT; Nadler LM; Cardoso AA
Blood; 2004 Mar; 103(5):1891-900. PubMed ID: 14615384
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis?
Barata JT; Cardoso AA; Boussiotis VA
Leuk Lymphoma; 2005 Apr; 46(4):483-95. PubMed ID: 16019476
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).
Barata JT; Cardoso AA; Nadler LM; Boussiotis VA
Blood; 2001 Sep; 98(5):1524-31. PubMed ID: 11520803
[TBL] [Abstract][Full Text] [Related]
6. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.
Okamoto N; Tezuka K; Kato M; Abe R; Tsuji T
Biochem Biophys Res Commun; 2003 Oct; 310(3):691-702. PubMed ID: 14550257
[TBL] [Abstract][Full Text] [Related]
7. IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells.
Fung MM; Rohwer F; McGuire KL
Cell Signal; 2003 Jun; 15(6):625-36. PubMed ID: 12681450
[TBL] [Abstract][Full Text] [Related]
8. Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.
Silva A; Gírio A; Cebola I; Santos CI; Antunes F; Barata JT
Leukemia; 2011 Jun; 25(6):960-7. PubMed ID: 21455214
[TBL] [Abstract][Full Text] [Related]
9. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kip1) cyclin-dependent kinase inhibitor.
Takami K; Takuwa N; Okazaki H; Kobayashi M; Ohtoshi T; Kawasaki S; Dohi M; Yamamoto K; Nakamura T; Tanaka M; Nakahara K; Takuwa Y; Takizawa H
Am J Respir Cell Mol Biol; 2002 Feb; 26(2):231-8. PubMed ID: 11804875
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen.
Richards JD; Davé SH; Chou CH; Mamchak AA; DeFranco AL
J Immunol; 2001 Mar; 166(6):3855-64. PubMed ID: 11238629
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
Moon JJ; Nelson BH
J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.
Brennan P; Babbage JW; Burgering BM; Groner B; Reif K; Cantrell DA
Immunity; 1997 Nov; 7(5):679-89. PubMed ID: 9390691
[TBL] [Abstract][Full Text] [Related]
14. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
[TBL] [Abstract][Full Text] [Related]
15. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells.
Chen D; Heath V; O'Garra A; Johnston J; McMahon M
J Immunol; 1999 Dec; 163(11):5796-805. PubMed ID: 10570262
[TBL] [Abstract][Full Text] [Related]
16. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
17. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
18. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
19. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.
Stahl M; Dijkers PF; Kops GJ; Lens SM; Coffer PJ; Burgering BM; Medema RH
J Immunol; 2002 May; 168(10):5024-31. PubMed ID: 11994454
[TBL] [Abstract][Full Text] [Related]
20. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]